We are live on
!
Find out more
NTC
North Tide Capital Portfolio holdings
AUM
$469M
1-Year Est. Return
6.57%
This Fund
S&P 500
This Quarter
Est. Return
+19.66%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$919M
AUM Growth
+$21.2M
(+2.4%)
Cap. Flow
-$61.3M
Cap. Flow
% of AUM
-6.67%
Top 10 Holdings %
Top 10 Hldgs %
85.67%
Holding
21
New
3
Increased
3
Reduced
3
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$65M |
| 2 |
Viatris
VTRS
|
+$33.3M |
| 3 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$30M |
| 4 |
Myriad Genetics
MYGN
|
+$25.4M |
| 5 |
Community Health Systems
CYH
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$50.2M |
| 2 |
Biogen
BIIB
|
+$48.4M |
| 3 |
KND
Kindred Healthcare
KND
|
+$44.4M |
| 4 |
AGN
Allergan plc
AGN
|
+$34.7M |
| 5 |
Avanos Medical
AVNS
|
+$24.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 81.16% |
| 2 | Consumer Discretionary | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
1
DELISTED
Select Medical
SEM
| $177M | 19.25% |
24,313,600
| – | – |
|
|
SVU
2
DELISTED
SUPERVALU Inc.
SVU
| $122M | 13.31% |
3,500,000
| – | – |
|
|
TVTY
3
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $119M | 12.96% |
4,500,000
| – | – |
|
|
4
Viatris
VTRS
$20.1B
| $76.2M | 8.3% |
2,000,000
+750,000
| +60% | +$33.3M |
|
|
5
Community Health Systems
CYH
$465M
| $63.5M | 6.91% |
5,500,000
+1,500,000
| +38% | +$17.3M |
|
|
6
Gilead Sciences
GILD
$167B
| $63.3M | 6.89% |
+800,000
| New | +$65M |
|
7
Bausch Health
BHC
$1.8B
| $49.1M | 5.35% |
2,000,000
-500,000
| -20% | -$12.9M |
|
8
Perrigo
PRGO
$1.48B
| $46.2M | 5.03% |
500,000
| – | – |
|
|
KND
9
DELISTED
Kindred Healthcare
KND
| $40.9M | 4.45% |
4,000,000
-4,000,000
| -50% | -$44.4M |
|
|
LPNT
10
DELISTED
LifePoint Health, Inc.
LPNT
| $29.6M | 3.22% |
+500,000
| New | +$30M |
|
|
AFAM
11
DELISTED
Almost Family Inc
AFAM
| $25.7M | 2.8% |
700,000
-550,000
| -44% | -$21.4M |
|
|
ELOS
12
DELISTED
Syneron Medical Ltd
ELOS
| $25.1M | 2.73% |
3,500,000
| – | – |
|
13
Option Care Health
OPCH
$3.41B
| $24.6M | 2.67% |
2,125,000
| – | – |
|
|
14
Myriad Genetics
MYGN
$584M
| $20.6M | 2.24% |
+1,000,000
| New | +$25.4M |
|
|
QHC
15
DELISTED
Quorum Health Corporation
QHC
| $15.7M | 1.71% |
2,500,000
+500,000
| +25% | +$4.1M |
|
|
VVUS
16
DELISTED
Vivus Inc
VVUS
| $15.5M | 1.69% |
1,358,746
| – | – |
|
17
Addus HomeCare
ADUS
$2.14B
| $4.55M | 0.5% |
174,079
| – | – |
|
|
18
Avanos Medical
AVNS
$1.17B
| – | – |
-750,000
| Closed | -$24.4M |
|
|
19
Biogen
BIIB
$30.4B
| – | – |
-200,000
| Closed | -$48.4M |
|
|
20
Brookdale Senior Living
BKD
$3.58B
| – | – |
-3,250,000
| Closed | -$50.2M |
|
|
AGN
21
DELISTED
Allergan plc
AGN
| – | – |
-150,000
| Closed | -$34.7M |
|
Similar funds
SD
DG
NBC
JWM
JPCCM
MCL
GIIO
FC
North Tide Capital's Q3 2016 Portfolio in Review
As of Q3 2016, North Tide Capital held 21 positions worth $919M, up 2.4% from $897M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
North Tide Capital withdrew a net $61.3M in Q3 2016, closing 4 positions and reducing 3 holdings. Its most notable exit was Brookdale Senior Living, an estimated $50.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 81% of assets, up from 78% a quarter earlier, followed by Consumer Discretionary.
Against the trend, North Tide Capital opened a new position in Gilead Sciences worth $63.3M.
- North Tide Capital's largest Q3 2016 buy was Gilead Sciences: 800,000 shares worth $63.3M.
- North Tide Capital added most to Viatris in Q3 2016, an estimated $33.3M increase.
- North Tide Capital's biggest Q3 2016 reduction was Kindred Healthcare, cutting an estimated $44.4M.
- North Tide Capital fully exited Brookdale Senior Living in Q3 2016, selling an estimated $50.2M.
- North Tide Capital's ten largest holdings make up 86% of its $919M portfolio in Q3 2016.
- North Tide Capital opened 3 new positions and closed 4 in Q3 2016.
- North Tide Capital's portfolio value rose 2.4% quarter-over-quarter to $919M.
Based on North Tide Capital's 13F filing for Q3 2016, filed 14 Nov 2016.